National Guideline Clearinghouse | CADTH therapeutic review recommendations: new oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation.

full-text ►
National Guideline Clearinghouse | CADTH therapeutic review recommendations: new oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation.

April 22, 2013

Guideline Title

CADTH therapeutic review recommendations: new oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation.

 

Bibliographic Source(s)

Canadian Agency for Drugs and Technologies in Health (CADTH). CADTH therapeutic review recommendations: new oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health (CADTH); 2012 Jun. 13 p. [18 references]

 

Guideline Status

This is the current release of the guideline.